Published in Cancer Weekly, February 12th, 2002
Ivax had requested the DC court to reconsider its prior ruling, which overturned for a second time a trial court ruling in favor of Ivax. The Appellate Court summarily denied the Ivax request for reconsideration of the Appellate Court ruling which found the FDA's approval for the Ivax generic product to be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.